VT-3989

N/A

Report date: 2026/03/12 20:00:16
NME

Base Information

Drug NameVT-3989
Drug Alias NameVT-3989
ClassificationSmall molecules
Mechanisms of ActionTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVivace Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVivace Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A